Study of a liver-protecting drug for blood cancer patients
Part of Digestive system clinical trials.
This trial is for people with blood cancers who are getting chemotherapy that can harm the liver. It tests if adding a specific liver-protecting injection can help prevent or treat liver damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a blood cancer, like leukemia, lymphoma, or myeloma, confirmed by a biopsy or lab test.
- You have had at least one round of chemotherapy that is known to sometimes cause liver problems.
- You are receiving a specific liver-protecting injection (polyene phosphatidylcholine), either alone or with certain other liver-protecting medicines.
- You have had a liver function blood test within 7 days before and after starting the liver-protecting treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether steroids (glucocorticoids) can help people with acute liver injury caused by a drug, especially when bilirubin levels are high. It aims to see if steroids can reduce liver damage and improve recovery.
This trial tests whether a medicine called polyene phosphatidylcholine can help protect the liver from damage after surgery for liver cancer. It is for people who are having a specific type of keyhole surgery to remove part of the liver.
This study looks at why some people develop liver inflammation after checkpoint inhibitor cancer treatment, called checkpoint inhibitor–induced liver injury (ChILI). It compares people with ChILI to similar cancer patients who are starting the same type of immunotherapy, to better understand and track these liver injury events.
This Phase 2 trial tests an injection medicine (F573) to see if it can improve people with liver injury, drug-related liver damage, or liver failure. You may be screened with blood tests, liver stiffness measurements, and possibly symptom checks.
This trial tests whether phycocyanin, a natural supplement, can protect the liver before and after surgery to remove part of the liver. It is for people with a type of bile duct cancer who are already getting chemotherapy and other treatments before surgery.
This trial tests a combination of immune “brakes” medicines (PD-1/PD-L1/CTLA-4) delivered through the liver’s artery, to help treat advanced liver cancer. It may help the immune system attack the cancer more effectively, especially if other local liver treatments aren’t possible or have stopped working.
Hear when a new Drug Induced Liver Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.